NO994898L - Cytomodulering av lipofile peptider for å modulere immunsystemaktivitet og inhibere inflammasjon - Google Patents
Cytomodulering av lipofile peptider for å modulere immunsystemaktivitet og inhibere inflammasjonInfo
- Publication number
- NO994898L NO994898L NO994898A NO994898A NO994898L NO 994898 L NO994898 L NO 994898L NO 994898 A NO994898 A NO 994898A NO 994898 A NO994898 A NO 994898A NO 994898 L NO994898 L NO 994898L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- activity
- lymphocytic
- inhibiting
- inhibit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83891697A | 1997-04-11 | 1997-04-11 | |
US09/028,083 US6696545B1 (en) | 1997-04-11 | 1998-02-23 | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
PCT/US1998/007231 WO1998046633A1 (en) | 1997-04-11 | 1998-04-10 | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO994898D0 NO994898D0 (no) | 1999-10-08 |
NO994898L true NO994898L (no) | 1999-11-24 |
Family
ID=26703275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994898A NO994898L (no) | 1997-04-11 | 1999-10-08 | Cytomodulering av lipofile peptider for å modulere immunsystemaktivitet og inhibere inflammasjon |
Country Status (14)
Country | Link |
---|---|
US (1) | US7267822B2 (ja) |
EP (1) | EP0973799B1 (ja) |
JP (1) | JP4550171B2 (ja) |
CN (1) | CN1216900C (ja) |
AT (1) | ATE352556T1 (ja) |
AU (2) | AU761717B2 (ja) |
BR (1) | BR9808529B1 (ja) |
CA (1) | CA2286478A1 (ja) |
IL (1) | IL132310A0 (ja) |
NO (1) | NO994898L (ja) |
NZ (1) | NZ500287A (ja) |
PL (1) | PL336302A1 (ja) |
TR (1) | TR199902786T2 (ja) |
WO (1) | WO1998046633A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2773240B1 (fr) | 1997-12-30 | 2002-11-29 | Synt Em | Procede pour prevoir, identifier et decrire des molecules susceptibles de presenter un comportement recherche, notamment dans le domaine de la pharmacie et molecules obtenues par ce procede |
MXPA01010541A (es) * | 1999-04-21 | 2003-08-19 | Univ Georgia Res Found | Cisteina proteasa e hinibidores para la prevencion y el tratamiento de la neurocisticercosis. |
US7094413B2 (en) | 2002-01-24 | 2006-08-22 | Sangstat Medical Corporation | Combined therapy for treatment of HIV infection |
KR20040094745A (ko) * | 2002-02-26 | 2004-11-10 | 상스타트 메디칼 코포레이션 | 세포제거 요법에 의해 유도된 위장 독성을 치료하는 방법및 조성물 |
FR2842738B1 (fr) * | 2002-07-23 | 2006-02-10 | Negma Lerads | Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus |
JP2006516546A (ja) * | 2002-11-15 | 2006-07-06 | サングスタット メディカル コーポレイション | 間質性膀胱炎の治療用細胞調節性ペプチド |
WO2005001075A1 (en) * | 2003-05-15 | 2005-01-06 | Sangstat Medical Corporation | Rdp58 compositions and methods for modulating the activity of osteoclasts and osteoblasts |
WO2005009457A1 (en) * | 2003-05-15 | 2005-02-03 | Sangstat Medical Corporation | Rdp58 compositions and methods for inhibiting vascularization of cell populations |
US7498309B2 (en) | 2003-11-29 | 2009-03-03 | Sangstat Medical Corporation | Pharmaceutical compositions for bioactive peptide agents |
CN104231054A (zh) * | 2014-09-01 | 2014-12-24 | 王跃建 | Il-10多肽抑制剂 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723128A (en) * | 1987-01-30 | 1998-03-03 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides |
EP0365525B1 (en) | 1987-01-30 | 1995-08-09 | The Board Of Trustees Of The Leland Stanford Junior University | Lymphocyte inhibition by hla peptides |
US5888512A (en) * | 1987-01-30 | 1999-03-30 | Board Of Trustees Of The Leland Stanford Junior University | Lymphocyte activity regulation by HLA peptides |
US5385888A (en) * | 1987-03-20 | 1995-01-31 | The Regents Of The University Of California | Class I MHC modulation or surface receptor activity |
JP3015058B2 (ja) | 1989-03-03 | 2000-02-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 表面レセプター活性のクラスimhc調節 |
NZ270605A (en) * | 1991-08-26 | 1997-07-27 | Cytel Corp | Cytotoxic t lymphocyte inducing peptides (6-19 amino acids) and pharmaceutical compositions thereof |
EP0661985B1 (en) | 1991-11-08 | 1999-07-07 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides capable of binding cd8 molecules on ctl precursors |
US5440015A (en) | 1992-07-21 | 1995-08-08 | Glycomed Incorporated | Selectin peptide medicaments for treating disease |
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
CA2176208A1 (en) * | 1993-11-10 | 1995-05-18 | Carol Clayberger | Surface membrane proteins and their effect on immune response |
CA2181787A1 (en) * | 1994-03-03 | 1995-09-08 | Claire M. Doerschuk | Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
CA2210812C (en) * | 1995-01-16 | 2009-09-01 | Nicholas Manolios | T-cell affecting peptides |
US6162434A (en) * | 1995-05-03 | 2000-12-19 | Sangstat Medical Corporation | Cytomodulating peptide for inhibiting lymphocyte activity |
US5753625A (en) * | 1995-05-12 | 1998-05-19 | Sangstat Medical Corporation | Treatment for inhibiting the progression of autoimmune disease |
WO1997024140A1 (en) | 1996-01-02 | 1997-07-10 | The Board Of Trustees Of Leland Stanford Junior University | Interaction of hla proteins with members of the hsp70 family of proteins |
US6436903B1 (en) | 1996-05-22 | 2002-08-20 | Stanford University (Board Of Trustees Of The Leland Standford Junior University) | Immunomodulating compounds comprising d-isomers of amino acids |
WO1997044351A1 (en) | 1996-05-24 | 1997-11-27 | The Board Of Trustees Of Leland Stanford Junior University | Immunomodulating dimers |
US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
-
1998
- 1998-04-10 CA CA002286478A patent/CA2286478A1/en not_active Abandoned
- 1998-04-10 AU AU68978/98A patent/AU761717B2/en not_active Ceased
- 1998-04-10 TR TR1999/02786T patent/TR199902786T2/xx unknown
- 1998-04-10 AT AT98914676T patent/ATE352556T1/de not_active IP Right Cessation
- 1998-04-10 WO PCT/US1998/007231 patent/WO1998046633A1/en active IP Right Grant
- 1998-04-10 JP JP54410298A patent/JP4550171B2/ja not_active Expired - Fee Related
- 1998-04-10 CN CN98806071XA patent/CN1216900C/zh not_active Expired - Fee Related
- 1998-04-10 PL PL98336302A patent/PL336302A1/xx not_active Application Discontinuation
- 1998-04-10 BR BRPI9808529-8A patent/BR9808529B1/pt not_active IP Right Cessation
- 1998-04-10 EP EP98914676A patent/EP0973799B1/en not_active Expired - Lifetime
- 1998-04-10 NZ NZ500287A patent/NZ500287A/xx not_active Application Discontinuation
- 1998-04-10 IL IL13231098A patent/IL132310A0/xx unknown
-
1999
- 1999-10-08 NO NO994898A patent/NO994898L/no not_active Application Discontinuation
-
2003
- 2003-09-05 AU AU2003244571A patent/AU2003244571B2/en not_active Ceased
-
2004
- 2004-02-17 US US10/780,321 patent/US7267822B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ500287A (en) | 2002-10-25 |
EP0973799B1 (en) | 2007-01-24 |
ATE352556T1 (de) | 2007-02-15 |
WO1998046633A1 (en) | 1998-10-22 |
AU6897898A (en) | 1998-11-11 |
AU2003244571A1 (en) | 2003-10-02 |
PL336302A1 (en) | 2000-06-19 |
JP2001526641A (ja) | 2001-12-18 |
CN1259958A (zh) | 2000-07-12 |
AU761717B2 (en) | 2003-06-05 |
IL132310A0 (en) | 2001-03-19 |
TR199902786T2 (xx) | 2000-06-21 |
CA2286478A1 (en) | 1998-10-22 |
AU2003244571B2 (en) | 2007-07-05 |
EP0973799A1 (en) | 2000-01-26 |
NO994898D0 (no) | 1999-10-08 |
US7267822B2 (en) | 2007-09-11 |
BR9808529B1 (pt) | 2010-10-05 |
BR9808529A (pt) | 2000-10-24 |
JP4550171B2 (ja) | 2010-09-22 |
US20040248810A1 (en) | 2004-12-09 |
CN1216900C (zh) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199801168T2 (xx) | �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri. | |
ATE415173T1 (de) | Pan dr-bindeproteinen zur erhöhung der immunantwort | |
EA199700135A1 (ru) | Ингибиторы клеточной адгезии | |
BR9811956B1 (pt) | naftiridinonas e composição farmacêutica compreendendo as mesmas. | |
DE69729786D1 (de) | Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen | |
Hong et al. | Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells | |
PL348147A1 (en) | Utilisation of dialkylfumarates | |
TR200000481T2 (tr) | N-Alkonoilfenilalenin türevleri. | |
TR200001982T2 (tr) | Farmasötik vurulu salınımlı oral dozaj şekli. | |
ATE63748T1 (de) | Enzymwiderstandsfaehige immunomodulatorische peptide. | |
DK0643726T3 (da) | Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei | |
EA199800119A1 (ru) | Ингибиторы адгезии клеток | |
NO992463D0 (no) | N-(aryl/heteroarylacetyl)aminosyreestere, farmas°ytiske sammensetninger som omfatter det samme, og metoder for inhibering av <beta>-amyloidpeptidfrigivelse og/eller dens syntese ved bruk av slike forbindelser | |
TR200103428T2 (tr) | IMPDH enzim inhibitörleri. | |
NO994898L (no) | Cytomodulering av lipofile peptider for å modulere immunsystemaktivitet og inhibere inflammasjon | |
AU5314900A (en) | Compositions and methods for inhibiting cell death | |
ATE286139T1 (de) | Replikationskompetente anti-tumor vektoren | |
LV10108A (lv) | Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni | |
NO971517D0 (no) | Peptider og farmasöytiske sammensetninger omfattende dem | |
WO1990007321A3 (en) | Lymphocyte receptor homing sequences and their uses | |
TR199802577T2 (xx) | Ayr� b�lmelerde iki aktif terkip maddeli transdermik sistemler. | |
DE69807672T2 (de) | Von milchsäure abgeleitete butyrat-prodrugs | |
Zaroukian | SURFACE LY-5 GLYCOPROTEIN IN MURINE NATURAL KILLER (NK) CELL DEVELOPMENT, TARGET BINDING AND CYTOTOXICITY: FUNCTIONAL STUDIES AND PRELIMINARY BIOCHEMICAL CHARACTERIZATION. | |
NO910981L (no) | Peptidforbindelser. | |
Jespersen | THE EFFECT OF ALPHA-FETOPROTEIN (AFP) AND OTHER CORD SERUM FRACTIONS ON MITOGEN-INDUCED LYMPHOCYTE TRANSFORMATION AND THE ONE-WAY MIXED LYMPHOCYTE REACTION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |